MENU
CGEM
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Cullinan Therapeutics (CGEM) Earnings Date & Reports

Cullinan Therapeutics Inc is a biopharmaceutical company... Show more

A.I. Advisor
published Earnings

CGEM is expected to report earnings to rise 13.49% to -87 cents per share on March 05

Cullinan Therapeutics CGEM Stock Earnings Reports
Q4'25
Est.
$-0.87
Q3'25
Beat
by $0.18
Q2'25
Missed
by $0.25
Q1'25
Beat
by $0.08
Q4'24
Beat
by $0.06
The last earnings report on November 06 showed earnings per share of -76 cents, beating the estimate of -94 cents. With 255.78K shares outstanding, the current market capitalization sits at 493.29M.
View a ticker or compare two or three
CGEM
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. CGEM showed earnings on November 06, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
One Main Street
Phone
+1 617 410-4650
Employees
85
Web
https://www.cullinanoncology.com